Tobias Klatte

Helios Hospital Bad Saarow — Germany

Medicine · Health Sciences

64h-index15.8kcitations544works6.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(277), Bladder and Urothelial Cancer Treatments(220), Renal and related cancers(150), Urinary and Genital Oncology Studies(86), Cancer Genomics and Diagnostics(55)

Publications528 total

Adjuvante Immuntherapie mit Pembrolizumab beim Nierenzellkarzinom – ist der neue Therapiestandard auch kosteneffektiv?
Die Urologie·2025
KDM6A expression loss is frequent in low grade non-invasive urothelial carcinomas of the urinary bladder
Pathologica·2025· 1 citedOpen Access
The Role of Salvage Cystectomy After Prior Trimodality Therapy: A Multinational Match-paired Analysis
European Urology Focus·2025· 1 citedOpen Access
Abstract 5860: Stimulator of interferon genes protein (STING) expression in tumor cells is linked to favorable disease parameters and a high density of tumor infiltrating inflammatory cells in urinary bladder cancer
Cancer Research·2025
Loss of chromosome Y is unrelated to the composition of the tumor microenvironment and patient prognosis in muscle-invasive urothelial bladder cancers
BMC Cancer·2025· 2 citedOpen Access
Hospital Volume as a Determinant of Outcomes After Partial Nephrectomy: A Systematic Review by the European Association of Urology Renal Cell Carcinoma Guidelines Panel
European Urology Oncology·2025· 5 cited
IP02-20 INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER PREVIOUSLY TREATED WITH BCG: RESULTS FROM THE EUROGEMDOCE GROUP
The Journal of Urology·2025
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update
European Urology·2025· 122 cited
835 HER2 Expression - Ultra-low to High - is a Common Event and Related to Aggressive Phenotype in Urothelial Bladder Carcinomas
Laboratory Investigation·2025Open Access
GATA3 amplification is associated with high grade disease in non-invasive urothelial bladder cancer but unrelated to patient prognosis
BMC Urology·2025· 2 citedOpen Access
The role of salvage cystectomy after prior trimodality therapy.
Journal of Clinical Oncology·2025· 1 cited
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma
European Urology·2025· 20 citedOpen Access
Gemcitabine and docetaxel for high‐risk non‐muscle‐invasive bladder cancer: <scp>EuroGemDoce</scp> group results
British Journal of Urology·2025· 12 citedOpen Access
Unmet needs in the management of patients with bilateral synchronous renal masses: the rationale for clinical decision-making
Minerva Urology and Nephrology·2025· 3 cited
Retrospective analysis of partial cystectomy in patients with muscle-invasive urothelial carcinoma: A German single-center experience
Urologic Oncology Seminars and Original Investigations·2024· 1 citedOpen Access
PLAP expression is linked to invasive tumor growth in urothelial carcinoma of the bladder
International Urology and Nephrology·2024· 1 citedOpen Access
Loss of <scp>MTAP</scp> expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer
The Journal of Pathology Clinical Research·2024· 9 citedOpen Access
Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, CancerCheck UBC Rapid VISUAL, and Uromonitor in Comparison to Cytology
Urology·2024· 5 cited
P239 MTAP and KDM6A immunohistochemistry enables identification of a large fraction of low grade urothelial bladder cancer
European Urology Open Science·2024Open Access
TYMS overexpression is frequent and linked to grade progression in urothelial bladder cancer
2024Open Access
page 1 of 27Next →

Frequent Co-authors

Allan J. Pantuck(22), Arie S. Belldegrun(21), Fairooz F. Kabbinavar(13), Michela de Martino(11), Brian Shuch(9), Jonathan Said(9), Shahrokh F. Shariat(9), Umberto Capitanio(7), David B. Seligson(7), Stephen B. Riggs(7), Matthias Waldert(7), Mesut Remzi(7), Alessandro Volpe(6), Nazy Zomorodian(6), Michael Marberger(6), Jeffrey C. LaRochelle(5), Jean‐Jacques Patard(5), Riccardo Campi(5), Ilaria Lucca(5), Andrea Haitel(5)